Rheumatoid Arthritis Clinical Trials in San Antonio

Showing 1761-1780 of 2,360 trials

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

NCT00006025

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of temozolomide plus irinotecan in treating patients who have recurrent malignant glioma.

Brain and Central Nervous System Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsStarted Jan 2001

Los Angeles, California, United States • San Francisco, California, United States • Bethesda, Maryland, United States +6 more locations

COMPLETEDPhase 2< 1 mile

Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma

NCT00003176

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of temozolomide and carmustine in treating patients with anaplastic glioma.

Brain and Central Nervous System Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins82 participantsStarted Mar 1998

Los Angeles, California, United States • San Francisco, California, United States • Boston, Massachusetts, United States +7 more locations

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma

Rheumatoid Arthritis Trials in Other Cities

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma

Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia

A Study in Participants With Rheumatoid Arthritis

A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate

A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).

Usability of an AI for M923 in Subjects With Moderate to Severe RA

Phase 1 and 2 Study of PX-866 and Cetuximab

Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens

The Usability and Injection Time of the Physiolis Syringe and Autoinjector in Rheumatoid Arthritis Patients

Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR)

Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections

PF-00489791 For The Treatment Of Raynaud's

Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets

A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting

A Prospective, Multicenter All Comers Study of Phasix Mesh for Ventral or Incisional Hernia Repair

OLIF25™ /OLIF51™ Study

Other Conditions in San Antonio